$1.78
-0.05 (-2.73%)
AVANIR Pharmaceuticals (AVNR)
CAPS Rating:
A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

RSS Headlines
Fool UK